References
- Berg K. J., Jerstad S., Tromsdal A. Studies on the clinical pharmacology of a new potent diuretic, Bay g 2821. Pharmatherapeutica 1976; 1: 3191. Berg K. J., Jerstad S., Tromsdal A. Studies on the clinical pharmacology of a new potent diuretic, Bay g 2821. Pharmatherapeutica 1976; 1: 319
- Hoppe-Seyler G. Personal communication 19762. Hoppe-Seyler g. Personal communication 1976
- Loew D. Diuretic action of Bay g 2821 in oedema-free volunteers. Curr. Med. Res. Opin. 1977; 4: 4553. Loew D. Diuretic action of Bay g 2821 in oedema-free volunteers. Curr. Med. Res. Opin. 1977; 4: 455
- Loew D., Meng K. The renal mechanism of Bay g 2821. Pharmatherapeutica 1977; 1: 3334. Loew D., Meng K. The renal mechanism of Bay g 2821. Pharmatherapeutica 1977; 1: 333
- Meng K., Loew D., Stoepel K., Hoffmeister F. Pharmacology of Bay g 2821, long-acting, high ceiling diuretic. Curr. Med. Res. Opin. 1977; 4: 5555. Meng K., Loew D., Stoepel K., Hoffmeister F. Pharmacology of Bay g 2821, long-acting, high ceiling diuretic. Curr. Med. Res. Opin. 1977; 4: 555
- Moller E., Horstmann H., Meng K., Loew D. 3-amino-1-(3, 4-dichlor-α-methyl-benzyl)-2 pyrazolin-5-one (Bay g 2821), a potent diuretic from a new substance class. Experientia. 1977, In Press6. Moller E., Horstmann H., Meng K., Loew D. 3-amino-1-(3, 4-dichlor-α-methyl-benzyl)-2 pyrazolin-5-one (Bay g 2821), a potent diuretic from a new substance class. Experientia. 1977, In Press
- Mussche M., Lameire N. The mechanism of action of Bay g 2821: a new diuretic. Curr. Med. Res. Opin. 1977; 4: 4627. Mussche M., Lameire N. The mechanism of action of Bay g 2821: a new diuretic. Curr. Med. Res. Opin. 1977; 4: 462